Should Fiduciaries Use NPV?
Comparing the Net Present Value (NPV) of a public company with its market capitalization is one of the most rigorous and reliable methods for assessing whether a stock is overvalued or undervalued.
Palantir (PLTR): Risk vs. Reality
At Equity Risk Sciences, we don’t deal in speculation—we quantify risk. Palantir (PLTR) may be growing, but is it a safe investment? The data tells a different story.
Palantir’s $178 Billion Valuation – Reality Check
At its peak, investors valued Palantir at $192 billion. Today, it’s $178 billion—but is it truly worth that much?
Reddit’s Market Cap Collapsed – Here’s Why
Last month, investors valued Reddit at $40.75 billion. Today? $19.4 billion—a 52% drop in just over 30 days. What went wrong? Was Reddit ever worth $40 billion? What’s stopping it from falling to $10 billion—or even lower?
Microsoft: A Case Study in Overpaying for Growth
Imagine holding Microsoft stock in 1999—one of the world's greatest companies—only to watch it lose 37% over the next decade. What went wrong? Overvaluation. In this video, we use Equity Risk Sciences’ Profit Map™ to break down why price matters more than growth and how investors can avoid these costly mistakes.
How Investors Lost $1.16 Trillion – Even as Revenues Soared
In 1999, investors were paying too much for the biggest stocks in the market. Over the next 10 years, revenues for these companies nearly doubled—but their stock prices collapsed. Why? Overvaluation. Investors paid too much.
Market Risk: Then vs. Now
How risky are the largest companies in the stock market today? We analyzed the top 10 companies from 12/31/1999 and 2/10/2025. Equity Risk Sciences' proprietary ratings have been identifying risk for decades, helping fiduciaries, investment advisors, and institutions protect capital and avoid major losses.
MDB: A Case Study in Risk—When the Data Screams “No”
Would you pay $37 billion for a company with $800 million in revenue and no history of success? Many investors do—but fiduciaries shouldn't.
How Reliable Are Stock Ratings? See the Data on Ciena (CIEN)
Our proprietary Price Risk Indicator™ (PRI™) and Fiduciary Risk Rating™ (FRR™) have consistently identified high-risk and low-risk periods for Ciena Corp (CIEN) over 10, 20, and 30 years—proving their effectiveness in avoiding catastrophic losses and capturing gains.
ERS’s Technology Indicates Unusually Profitable Buying Opportunities for NVIDIA
What if you could identify the exact moments when NVIDIA had the lowest possible investment risk and the highest probability of extraordinary returns? ERS’s Metric V1^2 uncovered three distinct periods—spanning 215 unique trading days out of 6,042 analyzed—where NVDA presented exceptional buying opportunities.